If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBk. Cyprus Hldg Regulatory News (BOCH)

Share Price Information for Bk. Cyprus Hldg (BOCH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 355.00
Bid: 354.00
Ask: 358.00
Change: 6.00 (1.72%)
Spread: 4.00 (1.13%)
Open: 358.00
High: 359.00
Low: 351.00
Prev. Close: 355.00
BOCH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 38.5 (EPT/RI)

21 Sep 2022 09:45

RNS Number : 1395A
Citigroup Global Markets Limited
21 September 2022
 

 

FORM 38.5(a) (EPT/RI)

 

IRISH TAKEOVER PANEL

 

DEALING DISCLOSURE UNDER RULE 38.5(a) OF THE IRISHTAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2022BY A CONNECTED EXEMPT PRINCIPAL TRADER WITHRECOGNISED INTERMEDIARY STATUS AND DEALING INA CLIENT-SERVING CAPACITY

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

Citigroup Global Markets Limited

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Bank of Cyprus Holdings plc

(c) Name of the party to the offer with which exempt principal trader is connected: (Note 1)

Lone Star Funds XI BidCo Limited

(d) Date dealing undertaken:

20 September 2022

(e) In addition to the company in 1(b) above, is the exempt principal trader also making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

 N/A

 

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER (Note 2)

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

Ap35

 

(a) Purchases and sales

 

Class of relevant security (Note 3)

Purchases/ sales

Totalnumber of securities

Highest price per unit paid/ received (GBP)

Lowest price per unit paid/ received (GBP)

€0.10 ordinary shares

Purchase

10,210

1.1700

1.1450

€0.10 ordinary shares

Sale

10,210

1.1700

1.1450

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description e.g. CFD

Nature of dealing e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities (Note 4)

Price perunit (Note 5)

 

 

 

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates (Note 4)

Exercise price per unit

Type  e.g. American, European etc.

Expirydate

Option money paid/ received per unit

 

 

 

 

 

 

 

 

 

(ii) Exercise

 

Class of relevant security

Product description e.g. call option

Exercising/ exercised against

Number of securities

Exercise priceper unit (Note 5)

 

 

 

 

 

 

(d) Other dealings (including transactions in respect of new securities)

 

Class of relevant security

Nature of dealing e.g. subscription, conversion, exercise

Details

Price per unit (if applicable) (Note 5)

 

 

 

 

 

Ap36

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

 

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

 

 

Date of disclosure:

 21 September 2022

Contact name:

Christopher Alexander Pollock

Telephone number:

028 95 954053

 

Public disclosures under Rule 38 of the Rules must be made to a Regulatory Information Service.

 

Ap37

 

NOTES ON FORM 38.5(a)

 

1. See the definition of "connected principal trader" in Rule 2.2 of Part A of the Rules.

 

2. See the definition of "dealing" in Rule 2.1 of Part A of the Rules.

 

3. See the definition of "relevant securities" in Rule 2.1 of Part A of the Rules.

 

4. See Rule 2.5(d) of Part A of the Rules.

 

5. If the economic exposure to changes in the price of securities is limited, for example, by virtue of a stop loss arrangement relating to a spread bet, full details must be given.

 

6. If details included in a disclosure under Rule 38 are incorrect, they should be corrected as soon as practicable in a subsequent disclosure. Such disclosure should state clearly that it corrects details disclosed previously, identify the disclosure or disclosures being corrected, and provide sufficient detail for the reader to understand the nature of the corrections. In the case of any doubt, the Panel should be consulted.

 

For full details of disclosure requirements, see Rules 8 and 38 of the Rules. If in doubt, consult the Panel.

 

References in these notes to "the Rules" are to the Irish Takeover Panel Act, 1997, Takeover Rules, 2022.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ISEEAPNFALLAEEA
Date   Source Headline
29th Apr 20209:39 amRNSBOCH Annual Financial Report 2019
29th Apr 20207:02 amRNSDoc re. (FY2019 Investor Presentation)
29th Apr 20207:00 amRNSFY2019 Group Financial Results
24th Apr 20209:29 amRNSNotice of AGM
16th Apr 20209:19 amRNSNotice of Results
15th Apr 20207:47 amRNSTR-1 Standard Form for Morgan Stanley
15th Apr 20207:37 amRNSChanges in the Board Composition
9th Apr 202012:08 pmRNSSecond Price Monitoring Extn
9th Apr 202012:02 pmRNSPrice Monitoring Extension
8th Apr 202012:08 pmRNSSecond Price Monitoring Extn
8th Apr 202012:03 pmRNSPrice Monitoring Extension
6th Apr 20204:41 pmRNSSecond Price Monitoring Extn
6th Apr 20204:36 pmRNSPrice Monitoring Extension
3rd Apr 202012:07 pmRNSSecond Price Monitoring Extn
3rd Apr 202012:02 pmRNSPrice Monitoring Extension
2nd Apr 20204:41 pmRNSSecond Price Monitoring Extn
2nd Apr 20204:36 pmRNSPrice Monitoring Extension
30th Mar 20204:41 pmRNSSecond Price Monitoring Extn
30th Mar 20204:36 pmRNSPrice Monitoring Extension
27th Mar 20204:40 pmRNSSecond Price Monitoring Extn
27th Mar 20204:36 pmRNSPrice Monitoring Extension
27th Mar 202012:07 pmRNSSecond Price Monitoring Extn
27th Mar 202012:02 pmRNSPrice Monitoring Extension
20th Mar 20204:44 pmRNSSecond Price Monitoring Extn
20th Mar 20204:37 pmRNSPrice Monitoring Extension
20th Mar 202010:25 amRNSAnnouncement
19th Mar 202012:07 pmRNSSecond Price Monitoring Extn
19th Mar 202012:03 pmRNSPrice Monitoring Extension
16th Mar 20206:05 pmRNSTrading Update
16th Mar 20205:55 pmRNSUpdate on Coronavirus & NPE Sale
16th Mar 20204:39 pmRNSPrice Monitoring Extension
13th Mar 20204:41 pmRNSSecond Price Monitoring Extn
13th Mar 20204:36 pmRNSPrice Monitoring Extension
21st Jan 202010:23 amRNSTR-1 Notification-Morgan Stanley
20th Jan 20208:34 amRNSTR-1 Notification-Caius Capital
2nd Dec 20191:50 pmRNSEthics, Conduct and Culture Committee (ECCC)
29th Nov 20195:24 pmRNSEU-wide Transparency Exercise 2019
29th Nov 201910:58 amRNSDate of Annual General Meeting
26th Nov 201910:49 amRNSInvestor Presentation of BOCH 9M2019 - Replacement
26th Nov 20197:04 amRNSInvestor Presentation of BOCH 9M2019 FR
26th Nov 20197:02 amRNSBOCH Group Financial Results 9M2019
7th Nov 20197:57 amRNSTR-1 Notification -Caius Capital
6th Nov 201912:54 pmRNSNotice of Results
31st Oct 20198:03 amRNSCompletion of Voluntary Staff Exit Plan
7th Oct 201912:05 pmRNSCompletion of the sale of investment in CNP
3rd Sep 201912:44 pmRNSTR-1 Notification of Major Holding- Caius Capital
2nd Sep 20192:59 pmRNSDirectorate Change
27th Aug 20198:23 amRNSInterim Financial Report 2019
27th Aug 20197:07 amRNSAppointment of Chief Executive Officer
27th Aug 20197:05 amRNSChanges in Group organisational structure

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.